Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Doximity (DOCS) Shares Outstanding (2020 - 2025)

Doximity has reported Shares Outstanding over the past 6 years, most recently at $185.0 million for Q4 2025.

  • Quarterly Shares Outstanding fell 1.38% to $185.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $185.0 million through Dec 2025, down 1.38% year-over-year, with the annual reading at $188.9 million for FY2025, 1.24% up from the prior year.
  • Shares Outstanding was $185.0 million for Q4 2025 at Doximity, down from $188.1 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $194.6 million in Q2 2023 and troughed at $82.9 million in Q1 2021.
  • The 5-year median for Shares Outstanding is $187.8 million (2024), against an average of $183.8 million.
  • Year-over-year, Shares Outstanding skyrocketed 165.49% in 2021 and then decreased 4.6% in 2024.
  • A 5-year view of Shares Outstanding shows it stood at $190.1 million in 2021, then increased by 1.67% to $193.3 million in 2022, then fell by 3.66% to $186.2 million in 2023, then increased by 0.76% to $187.6 million in 2024, then fell by 1.38% to $185.0 million in 2025.
  • Per Business Quant, the three most recent readings for DOCS's Shares Outstanding are $185.0 million (Q4 2025), $188.1 million (Q3 2025), and $187.5 million (Q2 2025).